Our analysis identified SREBF1 (encoding the SREBP1 protein) as a RUNX2 target in both TC (Fig. 2F-G) and BC cells (Fig. 6D, Fig. S4I), and its expression is significantly correlated with RUNX2 expression in TC patients (Fig. S5A). Here, RUNX2 is linked to breast cancer.